Okay, let's tackle this question about the best drug for controlling esophageal bleeding. First, I need to figure out the core concept here. Esophageal bleeding is commonly due to varices from portal hypertension, right? So the main goal is to reduce portal pressure quickly. The drugs involved would be ones that lower portal pressure.

The correct answer is probably a vasoconstrictor like octreotide or vasopressin. But wait, vasopressin is less used now because of side effects, so octreotide is preferred. Let me confirm that. Octreotide acts on somatostatin receptors, decreasing splanchnic blood flow. That reduces portal pressure effectively.

Now the options. Let's say the options are A: Vasopressin, B: Octreotide, C: Propranolol, D: Ligation. Wait, ligation is a procedure, not a drug. So if the question is about drugs, D is out. Propranolol is a non-selective beta-blocker. It's used for long-term prevention, not acute control. Vasopressin is older, but octreotide is better because of fewer side effects. So the correct answer is B: Octreotide.

Why the other options are wrong: Vasopressin (A) can cause severe vasoconstriction and coronary issues. Propranolol (C) is for maintenance, not acute. Ligation (D) is a procedure, not a drug. Clinical pearl: Remember that acute variceal bleeding is managed with octreotide or terlipressin, not vasopressin. Propranolol is for secondary prevention. So the key is acute vs. chronic management.

**Core Concept**
Esophageal variceal bleeding, secondary to portal hypertension, is best controlled by agents that reduce portal pressure. Vasoactive drugs like octreotide are preferred for acute management due to their superior safety profile and efficacy in decreasing splanchnic blood flow.

**Why the Correct Answer is Right**
Octreotide, a synthetic somatostatin analog, binds to somatostatin receptors in splanchnic vessels, reducing hepatic portal venous pressure. It decreases splanchnic blood flow and intrahepatic vascular resistance without significant systemic vasoconstriction, minimizing risks of coronary or mesenteric ischemia. It is the first-line pharmacologic agent for acute variceal bleeding, especially in resource-limited settings.

**Why Each Wrong Option is Incorrect**
**Option A: Vasopressin** causes severe vasoconstriction, increasing risks of myocardial infarction and mesenteric ischemia. **Option C: Propranolol** is a non-selective beta-blocker used for *secondary* prevention of variceal bleeding, not acute control. **Option D: Endoscopic ligation** is a mechanical intervention, not a drug, and is used alongside pharmacologic therapy.

**Clinical Pearl / High-Yield Fact**
Acute variceal bleeding requires immediate vasoactive therapy (e.g., octreotide or terlipressin) *before* endoscopy. Propranolol and nitrates are for long-term prophylaxis. Never use vasopressin alone in unstable patients due to high complication rates.

**Correct Answer: B. Octreotide**

✓ Correct Answer: A. Vasopressin